5(R)-5-Hydroxytriptolide

(5R)-5-羟基雷公藤内酯醇

Report date: 2026/01/27 10:16:52
NME

Base Information

Drug Name5(R)-5-Hydroxytriptolide
Drug Alias Name5(R)-5-hydroxytriptolide羟基雷公藤内酯醇LTS-Shanghai Pharmaceuticals Holding(5R)-Hydroxytriptolide雷腾舒 +[10] 
ClassificationNatural product/Extract
Mechanisms of ActionNitric oxide synthase, inducible inhibitorsImmunosuppressants
TargetsNitric oxide synthase, inducible
Therapy Area/IndicationsArthritis, RheumatoidAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of SciencesShanghai Pharmaceuticals Holding Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A